Wednesday February 10 2010 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
  • A-Z

Multiple Myeloma News and Headlines
Multiple Myeloma News updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's
Multiple Myeloma news alerts.
Site Map > Biotechnology News > Health News > Multiple Myeloma
.

Non-Homologous End-Joining Gene Profiling Reveals Distinct Expression Patterns Associated with Lymphoma and Multiple Myeloma
British Journal of Haematology:  similar ...
CancersGuide.com Guide to Cancer Treatments, Vaccines, Cancer Tests and Researches
PRLog:  similar ...
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for ...
PipelineReview:  similar ...
Managing Myeloma (www.ManagingMyeloma.com) Multi-supported Educational Initiative Continues to Introduce Excit
Pharma Live:  similar ...
University of Michigan Health System: Blood test could improve graft-versus-host disease treatment
NewsRX:  similar ...
Onyx, FDA Reach Agreement on Multiple Myeloma Drug Trial
FDA News:  similar ...
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Car
Pharmacy Choice:  similar ...
LLS increases maximum benefit for myeloma patients to $10,000
News-Medical.Net:  similar ...
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Carfilzomib Combination Trial in Relapsed Multiple Myeloma
SmartBrief:  similar ...
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Carfilzomib Combination Trial in Relapsed Multiple Myeloma
Earthtimes.org:  similar ...
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Carfilzomib Combination Trial in Relapsed Multiple Myeloma
FinanzNachrichten.de:  similar ...
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Carfilzomib Combination Trial in Relapsed Multiple Myeloma
Street Insider:  similar ...
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Carfilzomib C
NewsBlaze:  similar ...
BRIEF-Onyx announces agreement with FDA on SPA for cancer drug trial
Interactive Investor:  similar ...
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Carfilzomib Combination Trial in Relapsed Multiple Myeloma
Individual.com:  similar ...
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Carfilzomib Combination Trial in Relapsed Multiple Myeloma
Twin Cities Business Journal:  similar ...
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Carfilzomib Combination Trial in Relapsed Multiple Myeloma
Sacramento Business Journal:  similar ...
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Carfilzomib Combination Trial in Relapsed Multiple Myeloma
San Jose Business Journal:  similar ...
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Car
Pharma Live:  similar ...
The Leukemia & Lymphoma Society Increases Critical Benefit for Myeloma Patients
Triangle Business Journal:  similar ...

Search BioNews

      --- Advanced searching ---

 

Search BioWeb

      --- Advanced searching ---

 

BioPortfolio updates this list every 30 minutes so please bookmark and revisit regularly during the day:

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright © 1997-2009 - BioPortfolio Limited.